Man­u­fac­tur­ing roundup: Lotte nabs BMS fa­cil­i­ty in New York; Al­ca­mi ac­qui­si­tion com­plete

Bris­tol My­ers Squibb is hand­ing over the keys to its man­u­fac­tur­ing site in Syra­cuse, NY, to South Ko­re­an com­pa­ny Lotte Bi­o­log­ics.

BMS an­nounced this week that the sale of the fa­cil­i­ty is com­plete, with its di­ves­ture from the Syra­cuse man­u­fac­tur­ing site a part of an ef­fort to “evolve” the phar­ma’s man­u­fac­tur­ing net­work. As part of the deal, all em­ploy­ees will con­tin­ue to work for Lotte. BMS has al­so en­tered in­to a con­tract with Lotte to con­tin­ue man­u­fac­tur­ing some of its prod­ucts at the fa­cil­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER